Share on StockTwits
 

Equities Research Analysts’ ratings reiterations for Tuesday, January 7th:

Aurora Oil & Gas (TSE:AEF) had its outperform rating reissued by analysts at RBC Capital.

Barclays (NYSE:BCS) had its buy rating reissued by analysts at Espirito Santo Investment Bank Research.

Brookfield Infrastructure Partners L.P. (NYSE:BIP) had its sector perform rating reissued by analysts at Scotiabank.

BankUnited (NYSE:BKU) had its neutral rating reissued by analysts at Zacks. The firm currently has a $34.00 target price on the stock. Zacks’ analyst wrote, “BankUnited’s third-quarter earnings were well ahead of the Zacks Consensus Estimate. Results were primarily aided by growth in net interest income, partially offset by lower non-interest income and higher operating expenses. Loan and deposit balances improved during the quarter. Moreover, capital and profitability ratios remained strong. The company is conveniently positioned to grow both organically and inorganically, aided by healthy liquidity levels. Further, robust capital deployment plans and increasing emphasis on the commercial loan portfolio will prove accretive to its overall growth going forward. However, compressed net interest margin, exposure to disadvantageous residential loans and competitive markets will likely weigh on its financials in the near term. “

BP PLC (NYSE:BP) had its neutral rating reissued by analysts at Zacks. The firm currently has a $50.00 target price on the stock. Zacks’ analyst wrote, “We are maintaining our Neutral recommendation on BP Plc following its third quarter 2013 results. The company’s earnings beat the Zacks Consensus Estimate on high oil realization. However, the company’s strategy of offloading its non-core upstream properties will prove beneficial over time, while creating a portfolio with potentially stronger growth from a smaller base. Additionally, BP’s position in the Woodford, Haynesville, Fayetteville, Eagle Ford and Utica shale plays, in association with its vast resource base and profound knowledge in unconventional gas, will aid its natural gas operations going forward. However, headwinds from a number of global macro issues, such as sovereign debt risks, defaults on sovereign credits and changes in U.S. policies, are concerns for BP going forward. “

Commonwealth Bank of Australia (ASX:CBA) had its hold rating reiterated by analysts at Morningstar.

Coach (NYSE:COH) had its underperform rating reiterated by analysts at Zacks. They currently have a $50.00 price target on the stock.

Community Health Systems (NYSE:CYH) had its buy rating reiterated by analysts at Deutsche Bank.

DaVita HealthCare Partners (NYSE:DVA) had its neutral rating reissued by analysts at Zacks. Zacks currently has a $68.00 target price on the stock. Zacks’ analyst wrote, “We maintain our Neutral recommendation on DaVita as we expect strong revenues and financial strength to allow the company to overcome headwinds from increasing expenses and high dependence on commercial payors and government reimbursements. The company’s third quarter earnings surpassed the Zacks Consensus Estimate on lower tax expenses and strong performance from ancillary segment. The balance sheet also improved with lower debt and higher shareholder equity. Moreover, higher cash flow, rapidly expanding international presence and an active domestic acquisition strategy are other positives. The merger with HealthCare Partners bodes well for long-term growth. However, the HealthCare Partners segment is expected to be a drag 2014 owing to the MA rate cuts. “

Emera (TSE:EMA) had its sector perform rating reiterated by analysts at CIBC.

Equity Residential (NYSE:EQR) had its neutral rating reiterated by analysts at Zacks. They currently have a $55.00 price target on the stock. Zacks’ analyst wrote, “Equity Residential’s normalized FFO per share in third-quarter 2013 came in line with the Zacks Consensus Estimate and the prior-year quarter figure. Quarterly results were primarily driven by higher same store net operating income (NOI) and the benefit from stabilized Archstone properties. However, the positives were offset by the negative impact from disposition activity, common share issuance for the Archstone deal and elevated interest expense. Going forward, we believe Equity Residential’s focus on expansion in the high barrier-to-entry regions in the U.S. will drive top-line growth. Also, the echo boomers population continues to raise the demand for apartments. Alongside, with a decent balance sheet position, the company is well poised to capitalize on this favourable trend through acquisitions and developments. Yet, the company as a decent exposure to the Washington D.C. market, which has started experiencing a rise in new supply, thus posing a challenge for base rent growth in the near term. “

EXFO (NASDAQ:EXFO) had its sector perform rating reaffirmed by analysts at RBC Capital.

GameStop Corp. (NYSE:GME) had its buy rating reiterated by analysts at Janney Montgomery Scott.

Huntingdon Capital (TSE:HNT) had its sector perform rating reaffirmed by analysts at RBC Capital.

Las Vegas Sands Corp. (NYSE:LVS) had its buy rating reissued by analysts at Nomura. Nomura currently has a $80.00 price target on the stock, down from their previous price target of $93.00.

Magna International (TSE:MG) had its sector outperform rating reaffirmed by analysts at CIBC.

MGM Resorts International (NYSE:MGM) had its buy rating reiterated by analysts at Nomura. The firm currently has a $23.00 price target on the stock, down from their previous price target of $28.00.

North American Palladium (TSE:PDL) had its underperform rating reaffirmed by analysts at RBC Capital.

North American Palladium (TSE:PDL) had its sector underperform rating reissued by analysts at CIBC.

Pfizer (NYSE:PFE) had its neutral rating reaffirmed by analysts at Zacks. The firm currently has a $32.00 price target on the stock. Zacks’ analyst wrote, “Pfizer posted third quarter 2013 earnings of $0.58 per share, a couple of cents above the Zacks Consensus Estimate and 16% above the year-ago earnings. Revenues, which declined 2% to $12.643 billion, were just shy of the Zacks Consensus Estimate of $12.661 billion. Revenue growth was impacted by the loss of exclusivity of certain products including Lipitor, the expiry of the Spiriva collaboration in some countries, and purchasing patterns for Prevnar and Enbrel in some emerging markets. Revenues will be hit by genericization and the expiration of a few co-promotion agreements. The company’s pipeline needs to deliver given the Lipitor loss of exclusivity and the upcoming loss of exclusivity on additional products in the next few years. We remain Neutral on the stock.”

Sherritt International (TSE:S) had its sector perform rating reissued by analysts at CIBC.

Theravance (NASDAQ:THRX) had its neutral rating reaffirmed by analysts at Zacks. Zacks currently has a $38.00 target price on the stock. Zacks’ analyst wrote, “Theravance’s third quarter 2013 loss of $0.44 per share was narrower than the Zacks Consensus Estimate of a loss of $0.79 per share but wider than the year-ago loss of $0.37 per share. The wider year-over-year loss was due to lower revenues and higher costs. We are encouraged by Theravance’s decision to split into two separate publicly traded companies. We are also positive on the approval of COPD drugs Breo Ellipta and Anoro Ellipta in the U.S. The reintroduction of Vibativ in the U.S. is also encouraging. We prefer to remain on the sidelines until more visibility is obtained on commercialization of the drugs. Our target price is $38.00 per share.”

Whitecap Resources (TSE:WCP) had its sector outperform rating reiterated by analysts at CIBC.

Wynn Resorts (NASDAQ:WYNN) had its buy rating reaffirmed by analysts at Nomura. They currently have a $215.00 target price on the stock, down from their previous target price of $244.00.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.